MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.

msh id	COM:MERCKGROUP
symbol	MRK
name	MERCK Kommanditgesellschaft auf Aktien
homepage url	https://www.merckgroup.com
country	DE
sector	Healthcare
industry	Drug Manufacturers - Specialty & Generic
market	STOCKS
employee count	62.35K
crunchbase url	-
linkedin url	-
founders	-

market cap	70.26B
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-0.03
growth cost of revenue	0.09
growth depreciation and amortization	-0.21
growth ebitda	-0.14
growth ebitda ratio	-0.09
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-1
growth gross profit	-0.15
growth gross profit ratio	-0.1

COM:MERCKGROUP

Merck

Last Close

138.10

21/11 16:35

Market Cap

65.02B

Beta: -

Volume Today

214.14K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	18.3B
cost of revenue	18.3B
depreciation and amortization	1.92B
ebitda	6.29B
ebitda ratio	0.28
eps	7.02
eps diluted	7.02
operating expenses	8.23B
operating income	4.36B
operating income ratio	0.19

accounts receivables	-8.64M
capital expenditure	-4.88B
cash at beginning of period	2B
cash at end of period	2.14B
inventory	5.01B
working capital ttm	4.88B

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-